Sec Form 3 Filing - Lux Encore Sponsor, LP @ Lux Health Tech Acquisition Corp. - 2020-10-26

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Lux Encore Sponsor, LP 2. Issuer Name and Ticker or Trading Symbol Lux Health Tech Acquisition Corp. [ LUXA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR 3. Date of Earliest Transaction (MM/DD/YY) 10/26/2020 (Street) NEW YORK, NY10010 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Class B Common Stock ( 1 ) ( 1 ) ( 1 ) Class A Common Stock 8,505,000 I See footnote ( 2 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Lux Encore Sponsor, LP C/O LUX HEALTH TECH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR NEW YORK, NY10010 X Lux Encore Holdings, LLC C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR NEW YORK, NY10010 X Wolfe Josh C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR NEW YORK, NY10010 X Hebert Peter C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR NEW YORK, NY10010 X X Signatures Lux Encore Sponsor, LP, By: Lux Encore Holdings, LLC, its general partner, By: /s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert, Managing Member, By: /s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe, Managing Member 10/26/2020 Signature of Reporting Person Date Lux Encore Holdings, LLC, By: /s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert, Managing Member, By: /s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe, Managing Member 10/26/2020 Signature of Reporting Person Date /s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe 10/26/2020 Signature of Reporting Person Date /s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert 10/26/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Class B common stock will automatically convert into shares of Class A common stock at the completion of the Issuer's initial business combination on a one-for-one basis, subject to adjustment. ( 2 )Lux Encore Sponsor, LP ("Sponsor") is the record holder of the shares reported herein. Lux Encore Holdings, LLC ("Lux GP") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the Class B common stock held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Remarks: Exhibit ListExhibit 24.1 - Power of AttorneyExhibit 24.2 - Power of Attorney

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.